<?xml version="1.0" encoding="UTF-8"?>
<p id="d1e2002">Lymphocytopenia is an indicator of the severity and mortality in patients with coronavirus disease of 2019 (COVI-19) 
 <xref rid="b4" ref-type="bibr">[4]</xref>, 
 <xref rid="b28" ref-type="bibr">[28]</xref>, 
 <xref rid="b29" ref-type="bibr">[29]</xref>, 
 <xref rid="b30" ref-type="bibr">[30]</xref>, 
 <xref rid="b31" ref-type="bibr">[31]</xref>, 
 <xref rid="b32" ref-type="bibr">[32]</xref>, 
 <xref rid="b33" ref-type="bibr">[33]</xref>. Critically ill patients have significantly low lymphocyte count, possibly due to the direct infection by coronavirus, leading to cytoplasmic damage and destruction of cellular components 
 <xref rid="b30" ref-type="bibr">[30]</xref>, 
 <xref rid="b31" ref-type="bibr">[31]</xref>, 
 <xref rid="b33" ref-type="bibr">[33]</xref>, 
 <xref rid="b34" ref-type="bibr">[34]</xref>, 
 <xref rid="b35" ref-type="bibr">[35]</xref>. In addition, COVID-19 patients have hyperinflammatory responses that may induce massive recruitment of lymphocytes to the lung and result in the consequent pulmonary injury 
 <xref rid="b36" ref-type="bibr">[36]</xref>. These findings suggest that SARS-CoV-2 might rely on “cytokine storm” 
 <xref rid="b37" ref-type="bibr">[37]</xref> to develop a vicious cycle to drive lymphocytes to lung for infection to maintain the viral replication and transmissibility.
</p>
